Sep 13, 2017 11:00 am UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 13, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop...
ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 13, 2017 11:00 am UTC| Business
YONKERS, N.Y., Sept. 13, 2017 -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant...
Sep 13, 2017 11:00 am UTC| Business
HOLLYWOOD, Fla., Sept. 13, 2017 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, announced today that it was selected by the New...
Teekay Corporation Announces Changes to Board of Directors
Sep 13, 2017 10:55 am UTC| Business
HAMILTON, Bermuda, Sept. 13, 2017 -- Teekay Corporation (Teekay or the Company) (NYSE:TK) announced today the following changes to its Board of Directors: Axel Karlshoej, Director and Chairman Emeritus, and Thomas...
Sep 13, 2017 10:55 am UTC| Business
VANCOUVER, British Columbia, Sept. 13, 2017 -- Contact Gold Corp. (the “Company” or “Contact Gold”) (TSX-V:C) is pleased to announce that it has completed staking and acquiring an additional 270 unpatented mining claims...
PLx Pharma Retains Dr. Efthymios N. Deliargyris as Chief Medical Advisor
Sep 13, 2017 10:50 am UTC| Business
Dr. Deliargyris Brings More Than 25 Years of Expertise in Cardiovascular Medicine, Academia and the Biotech Industry PLx Pharma Continues to Build Foundation for Market-Readiness of Aspertec HOUSTON, Sept. 13, 2017 ...
Sep 13, 2017 10:45 am UTC| Business
STAMFORD, Conn., Sept. 13, 2017 -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that...